Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2025-12-31 @ 3:59 AM
Study NCT ID:
NCT01440595
Status:
TERMINATED
Last Update Posted:
2024-05-22
First Post:
2011-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2012-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-22
First Submit QC Date:
None
Study First Post Date:
2011-09-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-03
Results First Submit QC Date:
None
Results First Post Date:
2016-03-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-20
Last Update Post Date:
2024-05-22
Last Update Post Date Type:
ACTUAL